PubRank
Search
About
Daniel Lamontagne
Author PubWeight™ 12.24
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats.
J Hypertens
2003
1.41
2
Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.
J Hypertens
2003
1.40
3
Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats.
Circulation
2002
0.94
4
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.
Life Sci
2003
0.94
5
Endocannabinoids protect the rat isolated heart against ischaemia.
Br J Pharmacol
2003
0.93
6
Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts.
Life Sci
2007
0.89
7
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.
Cardiovasc Res
2002
0.89
8
Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies.
Cardiovasc Res
2005
0.85
9
Signaling pathways involved in the cardioprotective effects of cannabinoids.
J Pharmacol Sci
2006
0.84
10
Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings.
Life Sci
2005
0.83
11
Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats.
J Hypertens
2003
0.82
12
Rescue of amitriptyline-intoxicated hearts with nanosized vesicles.
Cardiovasc Res
2007
0.80
13
A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
Int Immunopharmacol
2003
0.78
14
The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
Can J Physiol Pharmacol
2005
0.75
15
Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction.
Can J Physiol Pharmacol
2003
0.75